99 related articles for article (PubMed ID: 21067422)
1. Hormone therapy and brain tumors.
Pines A
Climacteric; 2011 Apr; 14(2):215-6. PubMed ID: 21067422
[TBL] [Abstract][Full Text] [Related]
2. Risk of brain tumors associated with exposure to exogenous female sex hormones.
Wigertz A; Lönn S; Mathiesen T; Ahlbom A; Hall P; Feychting M;
Am J Epidemiol; 2006 Oct; 164(7):629-36. PubMed ID: 16835295
[TBL] [Abstract][Full Text] [Related]
3. A nationwide cohort study on the incidence of meningioma in women using postmenopausal hormone therapy in Finland.
Korhonen K; Auvinen A; Lyytinen H; Ylikorkala O; Pukkala E
Am J Epidemiol; 2012 Feb; 175(4):309-14. PubMed ID: 22287638
[TBL] [Abstract][Full Text] [Related]
4. Exogenous hormone use and meningioma risk: what do we tell our patients?
Claus EB; Black PM; Bondy ML; Calvocoressi L; Schildkraut JM; Wiemels JL; Wrensch M
Cancer; 2007 Aug; 110(3):471-6. PubMed ID: 17580362
[TBL] [Abstract][Full Text] [Related]
5. Postmenopausal hormone replacement therapy and meningioma.
Prescrire Int; 2010 Jun; 19(107):120. PubMed ID: 20738039
[TBL] [Abstract][Full Text] [Related]
6. Menopause and stroke and the effects of hormonal therapy.
Lobo RA
Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
[TBL] [Abstract][Full Text] [Related]
7. Lead, genetic susceptibility, and risk of adult brain tumors.
Rajaraman P; Stewart PA; Samet JM; Schwartz BS; Linet MS; Zahm SH; Rothman N; Yeager M; Fine HA; Black PM; Loeffler J; Shapiro WR; Selker RG; Inskip PD
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2514-20. PubMed ID: 17164378
[TBL] [Abstract][Full Text] [Related]
8. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
[TBL] [Abstract][Full Text] [Related]
9. Does the progesterone receptor genetic polymorphism +331G/A hPR influence the risk of venous thromboembolism among postmenopausal women using hormone therapy? The ESTHER Study.
Bouaziz E; Canonico M; Verstuyft C; Carcaillon L; Martin F; Scarabin PY; Guiochon-Mantel A;
Maturitas; 2009 Oct; 64(2):136-8. PubMed ID: 19782484
[TBL] [Abstract][Full Text] [Related]
10. [Progesterone+estrogen increased the risk of dementia in postmenopausal women. Surprising results of the WHIM study].
Fried G
Lakartidningen; 2003 Sep; 100(36):2742-3. PubMed ID: 14558187
[No Abstract] [Full Text] [Related]
11. Postmenopausal hormone therapy and lung cancer.
Pines A
Climacteric; 2011 Apr; 14(2):212-4. PubMed ID: 20950213
[TBL] [Abstract][Full Text] [Related]
12. Exogenous sex hormone use and risk of meningioma: a population-based case-control study in Finland.
Korhonen K; Raitanen J; Isola J; Haapasalo H; Salminen T; Auvinen A
Cancer Causes Control; 2010 Dec; 21(12):2149-56. PubMed ID: 20730482
[TBL] [Abstract][Full Text] [Related]
13. [Hormone therapy and risk for venous thromboembolism in postmenopausal women].
Lacut K; Oger E
Rev Prat; 2005 Feb; 55(4):389-92. PubMed ID: 15828617
[TBL] [Abstract][Full Text] [Related]
14. Estrogen and Progesterone Therapy and Meningiomas.
Hage M; Plesa O; Lemaire I; Raffin Sanson ML
Endocrinology; 2022 Feb; 163(2):. PubMed ID: 34935947
[TBL] [Abstract][Full Text] [Related]
15. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
Brinton RD
Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
[TBL] [Abstract][Full Text] [Related]
16. Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study.
Canonico M; Fournier A; Carcaillon L; Olié V; Plu-Bureau G; Oger E; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F; Scarabin PY
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):340-5. PubMed ID: 19834106
[TBL] [Abstract][Full Text] [Related]
17. Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women.
Tamimi RM; Hankinson SE; Chen WY; Rosner B; Colditz GA
Arch Intern Med; 2006 Jul; 166(14):1483-9. PubMed ID: 16864758
[TBL] [Abstract][Full Text] [Related]
18. Potential benefits of estrogens and progestogens on breast cancer.
Schneider HP; Jackisch C
Int J Fertil Womens Med; 1998; 43(6):278-85. PubMed ID: 9920536
[TBL] [Abstract][Full Text] [Related]
19. Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence.
Clarke CA; Glaser SL; Uratsu CS; Selby JV; Kushi LH; Herrinton LJ
J Clin Oncol; 2006 Nov; 24(33):e49-50. PubMed ID: 17114650
[No Abstract] [Full Text] [Related]
20. The breast cancer "plunge" after initial publication of the WHI results: an alternative explanation.
Simon JA; Nahum GG; Stanislaw H; Gaines T
Maturitas; 2010 Jul; 66(3):277-84. PubMed ID: 20471761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
